Bio-Spectrum India: ZIM Laboratories develops oral soluble strips

Nagpur-based ZIM Laboratories that develops and manufactures innovative and differentiated pharmaceutical products, has now developed affordable orally disintegrating strips (ODS) formulations up to 100 milligram that critically ill and bed-ridden patients can consume instead of swallowing tablets and taking painful injections.


These films, based on a patented oral thin film technology, adhere to the tongue mucosa and disintegrate almost instantaneously, when placed on the tongue. 
Market opportunity for the drug is huge in the country, as about Rs. 35,000 crore worth of drugs are delivered every year in oral solid dosage forms. 

Popular posts from this blog

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Serves Local Education Institute in Sanitation

ZIM Lab announces approval for Vitamin D3 Orally Disintegrating Film